Royalty Pharma plc
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
8/10
|
14.47 | 48.77 | -70.33% | 116.25 | -87.55% |
| P/S |
|
6.97 | 33.76 | -79.34% |
|
|
| P/BV |
|
1.63 | 4.82 | -66.22% |
|
|
| P/FCF |
|
14.38 | 61 | -76.43% |
|
|
| Ev/Ebitda |
|
14.8 | -22.15 | -166.81% |
|
|
| Ev/S |
|
9.38 | 22.56 | -58.44% |
|
|
| Ev/FCF |
|
24.1 | 68.78 | -64.96% |
|
|
| E/P |
|
0.0862 | 0.0178 | 384.99% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
10/10
|
63.37 | 4.98 | 1173.33% | 84 | -24.56% |
| ROE |
|
17.39 | 9.61 | 80.91% |
|
|
| ROA |
|
6.93 | 0.3443 | 1912.26% |
|
|
| ROIC |
|
6.21 | 7.63 | -18.66% |
|
|
| ROS |
|
48.2 | -25.17 | -291.5% |
|
|
| ROCE |
|
14.74 | 15.35 | -3.97% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
2/10
|
4.11 | -3.68 | -211.86% | 5.58 | -26.34% |
| Nеt Debt/Ebitda |
|
3.79 | -3.44 | -210.34% |
|
|
| Debt/Ratio |
|
0.3745 | 0.1985 | 88.69% |
|
|
| Debt/Equity |
|
2.41 | 1.66 | 44.74% |
|
|
| Debt/Net Income |
|
5.41 | 10.32 | -47.63% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
7.55/10
|
3.02 | 0.5442 | 454.93% | 2.08 | +45.05% |
| Number of years of dividend growth |
|
7 | 0.7368 | 850% | ||
| DSI |
|
0.9286 | 0.2237 | 315.13% |
|
|
| Average dividend growth |
|
17.57 | 0.9889 | 1676.58% |
|
|
| Average percentage for 5 years |
|
2.08 | 0.4952 | 320.42% |
|
|
| Average percentage for payments |
|
143.42 | 43.56 | 229.21% |
|
|
| Difference from average difference in sector |
|
2.48 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
4/10
|
29.8 | -56.89 | -152.38% | ||
| Growth impulse Ebitda in 5 years |
|
-31.47 | -54.68 | -42.45% | ||
| Growth impulse Net Income in 5 years |
|
-51.69 | -58.33 | -11.38% | ||
| Growth impulse FCF in 5 years |
|
79.23 | -49.48 | -260.13% | ||
| Growth impulse EPS in 5 years |
|
-71.61 | -32.41 | 120.95% |
IP Score
5.53/10
